Unidade Integrada de Farmacologia e Gastroenterologia Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2015
NCT02589301
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Unidade Integrada de Farmacologia e Gastroenterologia | UNIFAG - Unidade Integrada de Farmacologia e Gastroenterologia

Active Ingredients

Drugs in Phase 1 Trials (3)

epoetin (Epogen) (1 trial)

Filgrastim (neupogen) (3 trials)

zolpidem (ambien) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neutropenia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 5
  • # of Trial APIs: 3